MIRA – mira pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
MIRA Pharmaceuticals Reports Mira-55 Shows No THC- or Rimonabant-Associated CNS Side Effects in Preclinical Studies [Yahoo! Finance]
MIRA Pharmaceuticals (NASDAQ:MIRA) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating on the stock.
Form 8-K MIRA PHARMACEUTICALS, For: Mar 23
Form 8-K MIRA PHARMACEUTICALS, For: Mar 03
Form 5 MIRA PHARMACEUTICALS, For: Dec 31 Filed by: Aminov Erez
Form 8-K MIRA PHARMACEUTICALS, For: Feb 02
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.